RAINFOL-02 | NCT06619236

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Platinum Resistant Ovarian Cancer. Contact: RAINFOL-02@anzgog.org.au

RAINFOL-02 | NCT066192362026-06-24T21:10:36+10:00

ANVU | NCT06476639

The ANVU trial aims to determine whether groin ultrasound monitoring (1) is effective and safe to replace invasive groin LND to manage vulvar cancer; (2) decreases the morbidity associated with vulvar cancer surgery; and (3) is cost-effective.

ANVU | NCT064766392026-03-12T21:02:24+11:00

RAMP-301 | NCT06072781

The RAMP-301 trial will assess the safety and efficacy of the combination of Avutometinib plus Defactinib versus Investigator’s Choice of Treatment options (ICT) in patients with recurrent Low-grade Serous Ovarian Cancer (LGSOC) who have progressed on a prior platinum-based [...]

RAMP-301 | NCT060727812026-06-24T21:38:12+10:00

EN.10/TAPER | NCT05640999

The primary objective of this study is to estimate the rate of pelvic recurrence at 3 years in patients who are treated with de-escalated adjuvant treatment directed by tumour molecular status.

EN.10/TAPER | NCT056409992026-06-12T09:36:53+10:00

ENDO-3 | NCT04073706

ENDO-3 is a randomised controlled trial that compares sentinel lymph node dissection, a commonly performed procedure for the surgical staging of endometrial cancer, to no node dissection. The outcomes from this trial will provide high-level evidence on sentinel lymph node [...]

ENDO-3 | NCT040737062026-03-12T21:29:31+11:00
Go to Top